ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
- Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in...
- Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in...
Nabla Bio announced a new multi-year research collaboration with Takeda aiming to advance AI-driven design of protein therapeutics. This collaboration...
Trestle Biotherapeutics and Humacyte (Nasdaq: HUMA) have announced a research collaboration to explore technology synergies for bioengineering...
Collaboration will leverage Atavistik Bio’s proprietary AMPS™ platform to rapidly identify and validate novel allosteric binders against two undisclosed, Pfizer-designated...